- Direction
- Unknown
- Own history
- —
- Peers
- 69th
- Persistence
- TRANSIENT
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTHumacyte, Inc.'s latest supported as-filed period reports revenue of $406,000. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 8946.80% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 25.62% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -5433.74% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 34.88% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 1720.44% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value -203.20% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents increased 110.1%; Operating cash flow increased 16.5%.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 34.9%; Operating margin moved 322682 bp higher; Operating income increased 9.2%.
3 evidence-backed componentsCapital expenditure changed -81.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
HUMA · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001247296-26-000005SEC ↗4Oct 7, 2026Period Oct 6, 20260002156537-26-000004SEC ↗8-KSep 28, 2026Period Sep 22, 20260001818382-26-000011SEC ↗4Sep 15, 2026Period Sep 14, 20260001193125-26-391889SEC ↗4Aug 21, 2026Period Aug 20, 20260001193125-26-361081SEC ↗4Aug 19, 2026Period Aug 17, 20260001193125-26-356847SEC ↗10-QAug 12, 2026Period Jun 30, 20260001193125-26-347022SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Oct 6, 2026Filed Oct 7, 2026 | Kuznik Paul BrianDirector | Grant Or AwardDirect | 125,000 | $0 | $0 | Form 4 ↗ |
| Sep 14, 2026Filed Sep 15, 2026 | Jones Keith AnthonyDirector | Open Market PurchaseDirect | 10,000 | $1 | $5,620 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 21, 2026 | Jones Keith AnthonyDirector | Open Market PurchaseDirect | 10,000 | $1 | $6,930 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.operating_margin
Raw value -6649.26% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 4468.97% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 642.36% · OPTIONAL
Shares outstanding changed +75.4% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Cash & equivalents changed +110.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed -29.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +79.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +154.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed +153.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001104659-26-094440